Eligibility Pre-Screening

Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma

This is a simplified pre-screening tool. Your answers help estimate whether you might qualify, but only the research team can confirm your eligibility. This is not medical advice.

Question 1 of 50%

1.Have you been diagnosed with kidney cancer (renal cell carcinoma) that has spread to other parts of the body (metastatic)?

Press Y/N or 1/2